PRESS RELEASE
Paris, May 27, 2025


Air Liquide strengthens its Home Healthcare activity
with two acquisitions in Germany
Air Liquide is continuing its development in Germany with the acquisition of two outpatient intensive care
companies, intensivLeben GmbH and AP-Sachsen GmbH. With this operation, the Group broadens its
presence in the care market. Air Liquide accompanies more than 220,000 patients in Germany, with a
growing presence over the last 25 years. As part of its Healthcare activity, a Group’s growth driver,
Air Liquide already supports worldwide 2.1 million people at home living with a chronic disease and has
made Home Healthcare activities one of its strategic development priorities.

The newly acquired entities operate in the Saxony region, one of the most densely populated regions of
Eastern Germany, between Berlin and Bavaria where the Group is already present, with a strong footprint in
the local market. Both companies are operating in the German outpatient intensive care business, focusing
on Community Care centers, shared apartments for severe patients who suffer from chronic respiratory
insufficiency, craniocerebral trauma, and neuromuscular diseases. They provide personalized intensive
care to patients, and manage 9 centers, thanks to 138 employees, including around 100 nurses.

Air Liquide has been present in Germany in Home Healthcare for 25 years and has successfully managed to
become one of the major players in the Community care sector, with 20 Community Care centers across
Germany. Drawing on its experience and expertise in personalized support for patients, Air Liquide, through
these acquisitions, is strengthening its geographic footprint and its presence in services for chronic
patients.

Diana Schillag, member of Air Liquide's Executive Committee overseeing Healthcare, stated: "As
demographic change brings a growing need for medical care at home, intensive care services play an
essential role for the healthcare systems. With the new teams joining us, we strengthen our regional presence
in Germany by providing quality care to these patients and supporting their families. As a major player in
Home Healthcare throughout the world, our ambition is to improve the quality of life of patients to best meet
their needs at the lowest cost to society, thereby contributing to more efficient and sustainable healthcare
systems."


Air Liquide Healthcare
Air Liquide Healthcare is a world leader in medical gases, home healthcare services and specialty ingredients. Our 15,600
employees support 2.1 million chronic patients and provide medical gases and related services to 20,000 hospitals and new care
facilities, as well as 140,000 healthcare professionals. Committed to working alongside professionals and health institutions, our
patient-centered approach is based on the principle of Value-based Healthcare, which aims to improve the benefits experienced by
patients, at the best cost to society, thus contributing to a more efficient and virtuous system.




CONTACTS
Corporate Communications Investor Relations
media@airliquide.com IRTeam@airliquide.com



Air Liquide is a world leader in gases, technologies and services for industry and healthcare. Present in 60 countries with
approximately 66,500 employees, the Group serves more than 4 million customers and patients. Oxygen, nitrogen and hydrogen are
essential small molecules for life, matter and energy. They embody Air Liquide’s scientific territory and have been at the core of the
Group’s activities since its creation in 1902.
Taking action today while preparing the future is at the heart of Air Liquide’s strategy. With ADVANCE, its strategic plan, Air Liquide is
targeting a global performance, combining financial and extra-financial dimensions. Positioned on new markets, the Group benefits
from major assets such as its business model combining resilience and strength, its ability to innovate and its technological
expertise. The Group develops solutions contributing to climate and the energy transition — particularly with hydrogen — and takes
action to progress in areas of healthcare, electronics and high technologies.
Air Liquide’s revenue amounted to more than 27 billion euros in 2024. Air Liquide is listed on the Euronext Paris stock exchange
(compartment A) and belongs to the CAC 40, CAC 40 ESG, EURO STOXX 50, FTSE4Good and DJSI Europe indexes.


www.airliquide.com
Follow Air Liquide on LinkedIn